|
ABOUT US
 Janelle Park, M.D. was born in Columbia, Missouri, and grew up in Avon Lake, Ohio. She obtained her B.A. in Biology
with a minor in Art History from Columbia University in New York City, and her M.D. from the Ohio State University College
of Medicine. Dr. Park completed her medical internship at St. Luke's-Roosevelt Hospital in New York City, and then traveled
to Los Angeles to the University of Southern California for her radiation oncology residency training, where she served as
Chief Resident her senior year. While in the USC Radiation Oncology residency program, Dr. Park was trained in CyberKnife
as well as GammaKnife radiosurgery treatment planning and delivery.
Upon completion of her training, Dr. Park did a
brief stint in private practice in Southern California, and then returned to New York City in order to be closer to family.
While in New York, she was an assistant professor at the Mount Sinai School of Medicine and Clinical Director of the Bronx
Veterans' Administration's Radiation Therapy clinic. She also served as the chair of the Radiation Safety Committee and Director
of the Tumor Registry. Dr. Park moved back to warmer climates in 2009, joining Florida Radiation Oncology Group (FROG) and
becoming Medical Director of the Brandon Regional Hospital CyberKnife Cancer Center. Dr. Park is board-certified in
Radiation Oncology, and currently participates on the American College of Radiology's (ACR) Guidelines and Standards Committee,
as well as on the American College of Radiology's (ACR) Physics Committee. In addition, she is a member of American Society
for Therapeutic Radiation Oncology (ASTRO), American College of Radiology (ACR), and the American Medical Association (AMA).
 Mary Koshy, M.D. Mary Koshy was brought up in Sarasota, Florida and received her undergraduate training at Cornell
University where she graduated Suma Cum Laude. She received her medical school training at the University of Florida College
of Medicine in Gainesville, Florida.
She then went on to do her Internship in Internal Medicine at Emory University
in Atlanta, GA and stayed on to complete her residency in Radiation Oncology where she served as Chief Resident in her final
year. She stayed on at Emory for the following year on faculty as a Clinical Instructor and then served as Assistant Professor
in Radiation Oncology at Baylor College of Medicine in Houston for another 2 years before returning to Florida to join FROG
(Florida Radiation Oncology Group). Dr.Koshy spent her first 3 years with FROG in Jacksonville where she received CyberKnife®
training and helped to develop the radiosurgery program at Flagler Cancer Center in St Augustine, Fla. Dr Koshy has recently
come back to her hometown in Southwest Florida where she is Medical Director of the Manatee Cancer Center in Bradenton, Florida. Dr.
Koshy is a member of numerous organizations, including the American Society for Therapeutic Radiology and Oncology, the American
College of Radiology and The American Society of Clinical Oncology. She has authored several papers on IMRT, pediatric
tumors, gastrointestinal tumors, PET-CT imaging and MRI in the utilization of radiation therapy treatment planning . She has
been recipient of the ARS Young Oncologist Travel Award, RSNA Roentgen Research Award and the AAWR National Resident Award.
She maintains a strong interest in clinical research, and has a special interest in Intensity Modulated Radiotherapy, PET-CT
and gastrointestinal oncology. She is Board Certified in Radiation Oncology by the American Board of Radiology and a member
of the American Society for Therapeutic Radiation Oncology (ASTRO) and the American Society of Clinical Oncology (ASCO).
 Johnny Kao, M.D. is originally from New York City and graduated with honors from Dartmouth College. He completed
medical school training at Mount Sinai School of Medicine and radiation oncology residency training at University of Chicago.
He
served as Assistant Professor at Mount Sinai School of Medicine for 5 years where he started an active stereotactic body radiation
therapy program. At Mount Sinai, he developed and tested several new treatment combinations of radiation therapy and biologically
targeted anticancer treatments. For example, Dr. Kao was principal investigator of the first clinical trial to combine stereotactic
body radiation therapy with Sutent for patients with metastases to the lung, liver, bone or lymph nodes. Although metastatic
cancers have historically been considered incurable, approximately 30% of treated patients continue to be in a complete remission
more than 2 years after treatment. Dr. Kao also developed new treatment regimens for patients with advanced or recurrent head
and neck cancers, including patients that recurred after previous radiation. Dr. Kao joined Florida Radiation Oncology Group
in 2010 and is committed to bringing cutting edge treatment options to patients in Hillsborough County. Dr. Kao is a
member of numerous professional organizations, including American Society for Therapeutic Radiology and Oncology, American
Society of Clinical Oncologists and the American Association of Cancer Research. Dr. Kao was a past president of the New York
Roentgen Society Section of Radiation Oncology and is board certified in radiation oncology by the American Board of Radiology.
He has authored more than 30 peer-reviewed papers and 10 book chapters in the areas of prostate, head and neck and breast
cancers, stereotactic body radiation for metastatic tumors and cancer biology. He has been invited to speak at numerous local,
national and international cancer meetings. In addition to receiving nearly $2,000,000 in research grants, Dr. Kao was awarded
the Patients’ Choice award based on high patient satisfaction.
|
